Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis
Clinical trial NCT00656539 · COMPLETED
Trial details
- NCT number
- NCT00656539
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2008-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.